.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The state government officially launched the Ayushman Bharat West Bengal initiative to revamp the public healthcare sector. Chief Minister Suvendu Adhikari announced a massive Central sanction of around Rs 3,000 crore for this fiscal year. Specifically, this funding will address critical gaps in medical infrastructure and services across the state. Consequently, healthcare delivery in West Bengal is set to undergo a major transformation.
The total sanctioned package includes Rs 2,103 crore dedicated to the National Health Mission (NHM). Additionally, the Centre has already transferred Rs 500 crore to initiate immediate upgrades. Furthermore, the Union Government allocated Rs 976 crore specifically for implementing this flagship health insurance scheme. Therefore, these substantial funds will allow the state to modernize run-down facilities and secure essential supplies quickly.
The government plans to begin the distribution of health cards in July. Subsequently, six crore Swasthya Sathi card holders will transition to the Ayushman Bharat network in the first phase. Moreover, fresh applicants who did not participate in the earlier state-run scheme will also get an opportunity to enroll. Consequently, this change provides hospitalisation coverage of Rs 5 lakh per family annually.
The state will soon sign an agreement in Delhi to join the Ayushman Arogya Mandir network. This agreement will extend crucial healthcare benefits to over one crore migrant workers from the state. Furthermore, the administration plans to recruit doctors and nurses on a priority basis over the next three months. Consequently, this transparent recruitment policy will ensure better patient-to-provider ratios in state-run hospitals.
Q1: When will the Ayushman Bharat West Bengal card distribution start?
The distribution of the health cards is scheduled to begin in July, with enrollment activities already underway.
Q2: What will happen to existing Swasthya Sathi cardholders?
Approximately six crore Swasthya Sathi cardholders will transition to the Ayushman Bharat scheme in the first phase of the rollout.
Q3: How much financial coverage does the scheme provide?
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana provides a health coverage of Rs 5 lakh per family per year for secondary and tertiary care hospitalization.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
West Bengal Chief Minister Suvendu Adhikari announced a Rs 3,000 crore Central sanction to revamp state healthcare and roll out Ayushman Bharat from July....
4 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
